Clinical trial
Characterization of Renal Allograft Fibrosis and Prediction of Outcome Using a Quantitative MRI Approach
NCT05058170 is registered in ClinicalTrials.gov with Icahn School of Medicine at Mount Sinai as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Characterization of Renal Allograft Fibrosis and Prediction of Outcome Using a Quantitative MRI Approach
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- February 4, 2022
- Completion date
- April 30, 2026
- Enrollment
- 162 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
renal allograft fibrosis